4.6 Article

Archaea and the human gut: New beginning of an old story

Journal

WORLD JOURNAL OF GASTROENTEROLOGY
Volume 20, Issue 43, Pages 16062-16078

Publisher

BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.v20.i43.16062

Keywords

Human gut microbiota; Methanogens; Methanomassiliicoccus; Methanol methylophilus; Trimethylaminuria; Trimethylamine; Methane; Cardiovascular disease; Archaebiotics; Probiotics

Funding

  1. French Ministere de l'Enseignement Superieur et de la Recherche
  2. Science Foundation Ireland through a postdoctoral grant of the Alimentary Pharmabiotic Centre
  3. PhD Scholarship of the European Union (UE)
  4. Auvergne Council (FEDER)
  5. Science Foundation Ireland
  6. Department Agriculture, Fisheries and Marine of the Government of Ireland

Ask authors/readers for more resources

Methanogenic archaea are known as human gut inhabitants since more than 30 years ago through the detection of methane in the breath and isolation of two methanogenic species belonging to the order Methanobacteriales, Methanobrevibacter smithii and Methanosphaera stadtmanae. During the last decade, diversity of archaea encountered in the human gastrointestinal tract (GIT) has been extended by sequence identification and culturing of new strains. Here we provide an updated census of the archaeal diversity associated with the human GIT and their possible role in the gut physiology and health. We particularly focus on the still poorly characterized 7th order of methanogens, the Methanomassiliicoccales, associated to aged population. While also largely distributed in non-GIT environments, our actual knowledge on this novel order of methanogens has been mainly revealed through GIT inhabitants. They enlarge the number of final electron acceptors of the gut metabolites to mono- di- and trimethylamine. Trimethylamine is exclusively a microbiota-derived product of nutrients (lecithin, choline, TMAO, L-carnitine) from normal diet, from which seems originate two diseases, trimethylaminuria (or Fish-Odor Syndrome) and cardiovascular disease through the proatherogenic property of its oxidized liver-derived form. This therefore supports interest on these methanogenic species and its use as archaebiotics, a term coined from the notion of archaea-derived probiotics. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available